Clinical Trial: Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis
Detailed Summary:
Sponsor: Vistakon Pharmaceuticals
Current Primary Outcome: Ocular itching
Original Primary Outcome: Same as current
Current Secondary Outcome: Conjunctival, ciliary, and episcieral redness; chemosis and mucous discharge; tearing and lid swelling
Original Secondary Outcome: Same as current
Information By: Vistakon Pharmaceuticals
Dates:
Date Received: March 7, 2007
Date Started: February 2007
Date Completion:
Last Updated: April 8, 2009
Last Verified: April 2009